NCT03051204View on ClinicalTrials.gov

OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome

CompletedOBSERVATIONAL
Enrollment

175

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

December 11, 2018

Study Completion Date

December 11, 2018

Conditions
Crohn DiseaseUlcerative ColitisIrritable Bowel SyndromeCeliac DiseaseHealthy
Trial Locations (1)

90095

UCLA Center for Inflammatory Bowel Diseases, Los Angeles

Sponsors

Collaborators (1)

Genova Diagnostics
All Listed Sponsors
collaborator

Genova Diagnostics

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT03051204 - OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome | Biotech Hunter | Biotech Hunter